| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CSO and Director
1 company
Newman Michael James is a CSO and Director at INDP. Recent filings cover 0 purchases and 2 sales. Those positions are worth an estimated $205K at current prices.
Newman Michael James's largest disclosed position is in INDP as CSO and Director, worth about $205K. The recent filings there lean toward selling, a net 20,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2022 | INDP Indaptus Therapeutics, Inc. | CSO and Director | Sell | 20,000 | $5.00 | $100,042.98 | -1.4% | -37.6% | -65.8% |